Research analysts who have asked questions during Bon Natural Life earnings calls.
Recent press releases and 8-K filings for BON.
Bon Natural Life Limited announces Kombucha-inspired product launch and $12 million sales agreement
BON
Product Launch
New Projects/Investments
- Bon Natural Life Limited (BON) has launched a new Kombucha-inspired product designed for digestive health.
- BON entered into a non-exclusive strategic sales agreement with Shaanxi Qingshengyuan Health Industry Co., Ltd. for the distribution of these products in the Greater China market.
- The agreement, signed on December 5, 2025, has a term of 24 months and includes a guaranteed aggregate sales commitment of no less than $12 million from Qingshengyuan.
Dec 10, 2025, 11:15 AM
Bon Natural Life Launches Kombucha-Inspired Product and Signs $12 Million Sales Agreement
BON
Product Launch
New Projects/Investments
Revenue Acceleration/Inflection
- Bon Natural Life (BON) launched a new health-focused kombucha-inspired beverage produced from premium tea, sugar, and a Symbiotic Culture of Bacteria and Yeast (SCOBY).
- The company entered into a non-exclusive strategic sales agreement with Shaanxi Qingshengyuan Health Industry Co., Ltd., a leading distributor of functional health products in China.
- The agreement has a term of 24 months with a total contract value of $12 million, under which Qingshengyuan will sell and distribute BON's high-tea-pigment products across Greater China.
Dec 10, 2025, 9:00 AM
Bon Natural Life Announces New Product and Cooperation Agreement
BON
Product Launch
New Projects/Investments
- Bon Natural Life Limited (BON) announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd..
- The agreement has a term of 36 months and a total contract value of US$26 million.
- Under this agreement, Huahai Keyuan will sell and distribute BON's second-generation tea pigment-based digestive health products in Greater China.
- Testing indicates that the digestive health activity of BON's latest tea pigment product has increased by more than 200% compared to first-generation formulations.
Nov 25, 2025, 2:41 PM
Bon Natural Life Limited Announces Cooperation Agreement for Next-Gen Tea Pigment Digestive Health Products
BON
Product Launch
New Projects/Investments
Revenue Acceleration/Inflection
- Bon Natural Life Limited (BON) announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd. for the distribution of its second-generation tea pigment digestive health products in Greater China.
- The agreement, effective September 1, 2025, spans 36 months and includes a guaranteed aggregate sales commitment from Huahai Keyuan of no less than US$26,000,000 over its term.
- BON's new second-generation tea pigment product has shown a more than 200% increase in digestive health activity compared to first-generation formulations, positioning it for a market opportunity anticipated to exceed US$1 billion.
Nov 25, 2025, 2:30 PM
Bon Natural Life Limited Announces Interim 2025 Financial Results
BON
Earnings
Demand Weakening
- For the six months ended March 31, 2025, total revenues decreased by 21.9% to $7,949,845 compared to the same period in 2024. This decline was primarily driven by significant decreases in health supplemental powder drinks (97.6% decrease) and bioactive food ingredients (68.9% decrease), partially offset by a substantial 553.9% increase in fragrance compound products.
- Despite lower revenues, Bon Natural Life Limited reported a net income of $169,227 for the six months ended March 31, 2025, a significant improvement from a net loss of $10,519 in the prior year. Income from operations increased by 236.1% to $284,050.
- Basic earnings per share (EPS) for the six months ended March 31, 2025, was $0.56, reversing a loss per share of $0.20 from the comparable period in 2024.
- This profitability turnaround was supported by effective cost control, with total operating expenses decreasing by 43.7%. Notably, research and development expenses fell by 89.2%, selling expenses by 33.7%, and general and administrative expenses by 22.8%.
- As of March 31, 2025, the company's cash position significantly improved to $8,894,053 from $80,466 at September 30, 2024, contributing to total assets of $71,584,129 and total shareholders' equity of $53,905,305.
Sep 29, 2025, 1:27 PM
Quarterly earnings call transcripts for Bon Natural Life.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more